Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

MBX stock hub

MBX Biosciences, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

MBXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.9B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

MBX

In the news

Latest news · MBX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-25.7

P25 -105.6P50 -46.5P75 -3.1

ROIC-18.3

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All MBX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

176

Groups with data

Currency

USD

Showing 176 of 176 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001776111
Company name	MBX Biosciences, Inc.
Country	United States
Country code	US
Cusip	55287L101
Employees	63
Employees Change	20%
Employees Change Percent	46.51
Enterprise value	$1.5B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2024-09-13
Isin	US55287L1017
Last refreshed	2026-05-10
Market cap	$1.9B
Market cap category	Small-Cap
Price	$40.97
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	MBX
Tags	weight-loss
Website	https://mbxbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.44%
FCF yield	-4.1%
P/B ratio	4.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-86.6M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Profit Per Employee	$-1.4M
ROA	-17.68
ROCE	-22.55
ROE	-25.73
ROIC	-18.33

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	278.6%
EPS Growth Quarters	1
EPS Growth Years	2
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$452.7M
Cash	$440M
Current Assets	$448.5M
Current Liabilities	$14.6M
Debt	$555,000
Debt Equity	$0
Equity	$437.8M
Liabilities	$14.9M
Long Term Assets	$4.2M
Long Term Liabilities	$378,000
Net Cash	$439.4M
Net Cash By Market Cap	$22.55
Net Cash Growth	82.59%
Net Debt Equity	$-1
Tangible Book Value	$437.8M
Tangible Book Value Per Share	$9.2

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	30.79
Net Working Capital	$-5.8M
Quick ratio	30.42
Working Capital	$434M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-112.87%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	278.26%
200-day SMA	25.76
50-day SMA	30.91
50-day SMA vs 200-day SMA	50over200
All Time High	44.89
All Time High Change	-8.74%
All Time High Date	2026-01-15
All Time Low	4.81
All Time Low Change	752.19%
All Time Low Date	2025-04-07
ATR	2.68
Beta1y	1
Beta2y	1.95
Ch YTD	29.88
High	41.28
High52	44.89
High52 Date	2026-01-15
High52ch	-8.74%
Low	34.56
Low52	9.43
Low52 Date	2025-06-20
Low52ch	334.41%
Ma50ch	32.55%
Premarket Change Percent	2.16
Premarket Price	$35.46
Premarket Volume	15,171
Price vs 200-day SMA	59.06%
RSI	73.51
RSI Monthly	67.14
RSI Weekly	65.45
Sharpe ratio	1.49x
Sortino ratio	3.59
Total Return	-112.87%
Tr YTD	29.88
Tr1m	35.69%
Tr1w	37.56%
Tr3m	8.75%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	10
Analyst Count Top	6
Analyst Price Target Top	$60
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.59
Operating Income	$-98.8M
Price target	$56
Price Target Change	$36.7
Price Target Change Top	$46.47

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	29,075,328%
Float Percent	61.12%
Shares Insiders	2.82%
Shares Institutions	73.4%
Shares Out	47,570,485
Shares Qo Q	3.81%
Shares Yo Y	112.87%
Short Float	13.02%
Short Ratio	7.97
Short Shares	7.96

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-92.1M
Average Volume	506,479.5x
Bv Per Share	9.2
CAPEX	$-2.3M
Ch1m	35.69
Ch1w	37.56
Ch1y	278.3
Ch3m	8.75
Ch6m	60.21
Change	18.02%
Change From Open	17.24
Close	34.71
Days Gap	0.66
Depreciation Amortization	235,000
Dollar Volume	77,140,659
Earnings Date	2026-05-07
Earnings Time	bmo
EBIT	$-98.8M
EBITDA	$-98.6M
EPS	$-2.18
F Score	2
FCF	$-79.8M
FCF EV Yield	-5.29x
FCF Per Share	$-1.68
Financing CF	277,023,000
Fiscal Year End	December
Founded	2,018
Investing CF	-184,028,000
Ipr	156
Iprfo	78.11
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-12
Ma150	29.75
Ma150ch	37.68%
Ma20	32.4
Ma20ch	26.44%
Net CF	15,516,000
Next Earnings Date	2026-08-06
Open	34.94
Optionable	Yes
Position In Range	95.31
Post Close	40.97
Postmarket Change Percent	0.09
Postmarket Price	$41
Ppne	3,586,000
Pre Close	34.71
Price Date	2026-05-08
Ptbv Ratio	4.45
Relative Volume	3.72x
Share Based Comp	12,322,000
Tr6m	60.21%
Us State	Indiana
Volume	1,883,087

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does MBX pay a dividend?

Capital-return profile for this ticker.

Performance

MBX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns MBX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+73.4%

Float: +61.1% of shares outstanding

Insider ownership

+2.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

MBX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

73.5

Above 70: short-term overbought

Price vs 200-day MA

+59.1%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.49

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About MBX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current MBX stock rating?

MBX Biosciences, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full MBX analysis?

The full report lives at /stocks/MBX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for MBX?

The latest report frames MBX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the MBX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.